About revvity inc. - RVTY
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.
RVTY At a Glance
Revvity, Inc.
77 Citypoint 4th Avenue
Waltham, Massachusetts 02451
| Phone | 1-781-663-6900 | Revenue | 2.86B | |
| Industry | Medical Specialties | Net Income | 239.88M | |
| Sector | Health Technology | 2025 Sales Growth | 3.667% | |
| Fiscal Year-end | 12 / 2026 | Employees | N/A | |
| View SEC Filings |
RVTY Valuation
| P/E Current | 48.372 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 47.20 |
| Price to Sales Ratio | 3.964 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | 19.46 |
| Enterprise Value to EBITDA | 18.073 |
| Enterprise Value to Sales | 4.822 |
| Total Debt to Enterprise Value | 0.245 |
RVTY Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | 3.835 |
| Total Asset Turnover | 0.233 |
RVTY Liquidity
| Current Ratio | 1.682 |
| Quick Ratio | 1.397 |
| Cash Ratio | 0.691 |
RVTY Profitability
| Gross Margin | 43.024 |
| Operating Margin | 12.487 |
| Pretax Margin | 9.393 |
| Net Margin | 8.399 |
| Return on Assets | 1.953 |
| Return on Equity | 3.216 |
| Return on Total Capital | 2.259 |
| Return on Invested Capital | 2.285 |
RVTY Capital Structure
| Total Debt to Total Equity | 46.455 |
| Total Debt to Total Capital | 31.72 |
| Total Debt to Total Assets | 27.68 |
| Long-Term Debt to Equity | 38.334 |
| Long-Term Debt to Total Capital | 26.174 |